DE602004027655D1 - Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set - Google Patents

Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set

Info

Publication number
DE602004027655D1
DE602004027655D1 DE602004027655T DE602004027655T DE602004027655D1 DE 602004027655 D1 DE602004027655 D1 DE 602004027655D1 DE 602004027655 T DE602004027655 T DE 602004027655T DE 602004027655 T DE602004027655 T DE 602004027655T DE 602004027655 D1 DE602004027655 D1 DE 602004027655D1
Authority
DE
Germany
Prior art keywords
treatment
mucosa
charged lipid
disorder
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004027655T
Other languages
English (en)
Inventor
Yechezkel Barenholz
Abraham Rubinstein
Tareq Jubeh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of DE602004027655D1 publication Critical patent/DE602004027655D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DE602004027655T 2003-11-03 2004-11-03 Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set Active DE602004027655D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51631603P 2003-11-03 2003-11-03
PCT/IL2004/001005 WO2005041932A2 (en) 2003-11-03 2004-11-03 Method for selecting cationic or anionic liposomes for treatment of a mucosa membrane, and kit comprising the same

Publications (1)

Publication Number Publication Date
DE602004027655D1 true DE602004027655D1 (de) 2010-07-22

Family

ID=34549524

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004027655T Active DE602004027655D1 (de) 2003-11-03 2004-11-03 Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set

Country Status (5)

Country Link
US (1) US20070212403A1 (de)
EP (1) EP1694298B1 (de)
AT (1) ATE470435T1 (de)
DE (1) DE602004027655D1 (de)
WO (1) WO2005041932A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004233873B2 (en) 2003-04-25 2010-11-18 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US20070087045A1 (en) * 2005-10-14 2007-04-19 Industrial Technology Research Institute Lipid carrier and method of preparing the same
EP2123259A1 (de) * 2007-01-16 2009-11-25 Hokkaido University Liposom-zubereitung für die iontophorese mit einem darin eingekapselten antioxidans-bestandteil
EP2368627A4 (de) * 2008-12-24 2015-01-14 Biomedcore Inc Verfahren zur herstellung von liposomen und verfahren zur cholesterinauflösung
EP2675918B1 (de) * 2011-02-15 2017-11-08 Merrimack Pharmaceuticals, Inc. Zusammensetzungen und verfahren zur nukleinsäurefreisetzung in einer zelle
CN102192978B (zh) * 2011-03-15 2013-09-04 中国科学院武汉病毒研究所 评价作用于体内粘膜的药物和外源物安全性的方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0714865B2 (ja) * 1986-10-28 1995-02-22 武田薬品工業株式会社 リポソ−ム製剤およびその製造法
US4918063A (en) * 1987-02-17 1990-04-17 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
WO1993014744A1 (en) * 1992-02-04 1993-08-05 Chiron Corporation Non-toxic lipid vaccine formulations
US20020039556A1 (en) * 1995-09-27 2002-04-04 Kari Dyvik Stabilised phospholipid compositions
AU753196B2 (en) * 1998-02-09 2002-10-10 Bracco Research S.A. Targeted delivery of biologically active media
US6872406B2 (en) * 2000-02-11 2005-03-29 Children's Hospital Research Foundation Fusogenic properties of saposin C and related proteins and polypeptides for application to transmembrane drug delivery systems
US6616944B2 (en) * 2000-03-08 2003-09-09 Medinnova Gesellschaft Fur Medizinsche Innovationen Aus Adkademischer Forschung Mbh Self-assembling colloidal carriers for protein delivery
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes
CN1320923C (zh) * 2001-06-29 2007-06-13 中外制药株式会社 含有基于癌抑制基因wt1的产物的癌抗原和阳离子脂质体的癌疫苗

Also Published As

Publication number Publication date
WO2005041932A3 (en) 2005-06-02
US20070212403A1 (en) 2007-09-13
WO2005041932A2 (en) 2005-05-12
EP1694298B1 (de) 2010-06-09
EP1694298A2 (de) 2006-08-30
ATE470435T1 (de) 2010-06-15

Similar Documents

Publication Publication Date Title
ATE309802T1 (de) Verwendung von cyclopamine zur behandlung von psoriasis und anderen hauterkrankungen
AR066292A1 (es) Tratamiento para la degeneracion macular relacionada con el envejecimiento utilizando inhibidores de factor d complementario
CL2011003346A1 (es) Compuestos derivados de 2,3-dihidro-5h-[1,3]tiazolo[3,2-a]pirimidin-5-ona, moduladores de pi3k; composicion farmaceutica; y uso para tratar una enfermedad de base inmunologica, cancer o enfermedad pulmonar en un paciente.
BRPI0412893A (pt) composto, composição farmacêutica, uso de um composto, e, métodos de prevenção, tratamento ou melhora de doenças ou condições inflamatórias, ou doenças ou condições oftálmicas, de tratamento ou melhora de cáncer e para a produção de um composto
ATE291614T1 (de) Diagnose und behandlung von zellproliferativen erkrankungen mit beteiligung von klonalen makrophagen
ATE540129T1 (de) Target zur therapie kognitiver behinderungen
CY1107780T1 (el) Μεθοδος για τη θεραπεια οφθαλμικων νεοαγγειακων ασθενειων
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
Yang et al. Sihler-stain study of buccal nerve distribution and its clinical implications
DE602004027655D1 (de) Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set
BRPI0415215A (pt) aplicação de um polifenol para o tratamento de uma lesão cancerosa ou pré-cancerosa da pele
DE60140960D1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
ATE398456T1 (de) Verwendung von negativ-geladenen phospholipiden zur herstellung eines medikaments zur behandlung und/oder vorbeugung von makuladegeneration
BR0313081A (pt) Combinação de um inibidor de aromatase com um bisfosfanato
DE69924146D1 (de) Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
DE60005952D1 (de) Löslische hla-g enthaltende zusammensetsungen zur behandlung entzündlichen hautkrankheiten
Manzon et al. Injuries on a skull from the Ancient Bronze Age (Ballabio, Lecco, Italy): a natural or an anthropic origin?
ATE338558T1 (de) Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern
BR0311613A (pt) Métodos para inibição, tratamento ou prevenção de sintomas de atrofia da pele, ou atrofia epitelial ou da mucosa nas mulheres e utilização de composto
EA200501456A1 (ru) Торий- 227 для применения в радиотерапии заболевания мягких тканей
DE602004030661D1 (de) Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis
MX2023002350A (es) Composiciones y metodos para mejorar enfermedades y trastornos neurologicos.
DE60131100D1 (de) Verfahren zur behandlung bestimmter augenkrankheiten
MX2022012632A (es) Uso de inhibidores del bromodominio para el tratamiento de la enfermedad de huntington.
Teng et al. Tumor arising in the right sciatic nerve of a 58-year-old man.